Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EN-374 gene therapy in adults with X-linked chronic granulomatous disease
ISRCTN13098265Phase 2Recruiting
- Sponsor
- Catalyst Clinical Research
- Start
- Aug 2025
- Modality
- Gene Therapies
01
Overview
Phase 2, open-label trial of EN-374 in X-linked chronic granulomatous disease (X-CGD), sponsored by Catalyst Clinical Research. Started Aug 2025; status: recruiting.
02
Drugs
EN-374
03
Conditions
X-linked chronic granulomatous disease (X-CGD)
Beyond the preview
Go deeper on ISRCTN13098265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13098265.